Anzeige
Mehr »
Donnerstag, 01.01.2026 - Börsentäglich über 12.000 News
Schon +250% im Plus - warum diese Goldstory gerade erst startet!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiMeta Platforms stock holds steady as BMO Capital reiterates $710 price target
MiBaird reiterates Outperform rating on Axsome Therapeutics stock
MiSOL Strategies announces credit facility restructuring with former chairman
MiElanco receives USDA approval for canine dermatitis treatment
MiAxsome stock jumps on FDA priority review for Alzheimer's agitation drug
MiMizuho raises Axsome Therapeutics stock price target on regulatory progress
MiGoldman Sachs outlines top investment themes for 2026
MiGoldman Sachs forecasts 11% S&P 500 rise in 2026 amid economic growth
MiOppenheimer raises Axsome Therapeutics stock price target to $220 on FDA news
MiTruist Securities lowers Corcept Therapeutics stock price target on FDA concerns
MiMorgan Stanley reiterates Overweight rating on Axsome stock with $196 target
Mi30-year mortgage rate drops to 2025 low at 6.15%
MiHyatt Hotels price target raised to $164 from $158 at Stifel
MiInternational isotopes announces name change to radnostix
MiZealand Pharma reports 71.5 million shares outstanding at year-end
MiTigress Financial reiterates Buy rating on Fiserv stock with $95 price target
MiQvantel completes acquisition of Optiva, secures four new operator wins
MiMatthews completes $232.1 million sale of warehouse automation business
MiWolfe Research downgrades Corcept Therapeutics stock rating to Underperform
MiAutoliv retires 1.26 million repurchased shares, reduces issued total
MiFormer MUFG executive DuChene joins company's Americas board
MiUltragenyx Pharma stock rating reiterated at Outperform by Leerink
MiLake Street assumes coverage on Limoneira stock with Buy rating
MiHot Rocks Investments reports £423,610 profit in first half
MiClearmind regains Nasdaq compliance as shares maintain $1 minimum